Yes. HiRO combines strong local and regional expertise with global clinical standards to support clinical trials across North America, Europe, Asia-Pacific, and ANZ. HiRO’s teams include regionally based professionals with deep understanding of local regulations, site networks, regulatory authorities, and clinical practices, enabling efficient trial execution within each geography. This localized insight, supported by centralized global oversight, ensures compliant, high-quality delivery across all regions.
GLOBAL. REGIONAL. SEAMLESS.
The Modern Global CRO
Biotechs Trust
HiRO supports clinical development across regions through globally aligned teams, region-specific insight, and a biometrics-driven foundation that keeps data flowing smoothly. From approvals to execution, we bring clarity to complexity and coordinate study operations across borders – helping biotechs move with confidence and predictable oversight at every step.
Sponsors Rely On HiRO’s Global-to-Regional Model
Biotechs choose HiRO because our regions operate on unified standards strengthened by deep local expertise and a connected data environment. Every region functions through our One HiRO Linkage™ Approach, ensuring consistency, transparency, and steady communication as studies transition seamlessly across countries and milestones.
GLOBAL STANDARDS. REGIONAL EXPERTISE.
Unified Clinical Execution
Across Every Region
With consistent communication, aligned processes, and global standards, HiRO’s regional model ensures every study benefits from disciplined oversight. Sponsors gain confidence knowing crossborder work is coordinated, predictable, and supported by teams who bring local understanding to every decision.
Aligned Teams. Steady Delivery.
HiRO’s regions operate through a shared biometrics foundation and unified operational frameworks, allowing studies to transition seamlessly across countries without losing quality or context. Each region contributes deep local expertise while upholding the clarity, structure, and discipline that define our global approach.
Clarity That Scales Globally.
Our teams communicate with the calm, steady transparency sponsors rely on for multi-country programs. Whether a study is anchored in one region or expands across several, HiRO provides clear expectations, aligned updates, and guidance grounded in real-time data – helping biotechs move forward with confidence.
COMMON REGIONAL QUESTIONS
Frequently Asked
Regional Questions
How does HiRO manage regional differences in trial startup timelines?
HiRO manages regional trial startup timelines by integrating global project oversight with local regulatory and operational expertise in each region. Regionally based teams apply in-depth knowledge of country-specific regulatory requirements, ethics review processes, and site startup practices to streamline approvals and mitigate delays. This coordinated global-local approach helps ensure efficient, predictable trial startup across regions.